STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CRNX CRINETICS PHARMACEUTICALS INCORPORATED StockScouter® Report

7

StockScouter® Score

CRINETICS PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
  • An executive, director or major shareholder purchased a large number of shares recently. Postive/Neutral

 

Concerns

  • One or more analysts has modestly decreased quarterly earnings estimates for CRNX. Negative
  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 100% done.
Low
High

Core Model Grades

A
A
N/A
D

Previous Ratings

3
2
2